Events

Safety Alert for Piperacilin - Tazobactam

According to Health Ministry (Panama), this safety alert involved a device in Panama that was produced by Pharmayect SA, Laboratorio Libra SA, Laboratorio Richet SA, Aurobindo Pharma Ltd.

What is this?

Alerts provide important information and recommendations about products. Even though an alert has been issued, it does not necessarily mean a product is considered to be unsafe. Safety Alerts, addressed to health workers and users, may include recalls. They can be written by manufacturers, but also by health officials.

Learn more about the data here
  • Type of Event
    Safety alert
  • Date
    2016-06-10
  • Event Date Posted
    2016-06-22
  • Event Country
    Panama
  • Event Source
    HMP
  • Event Source URL
    http://www.minsa.gob.pa/informacion-salud/alertas-y-comunicados?title=&field_decree_date_value%5Bvalue%5D%5Byear%5D=2016&page=1
  • Notes / Alerts
    Panamanian data is current through January 2019. All of the data comes from the Health Ministry (Panama), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Panama.
  • Extra notes in the data
  • Reason
    In japan there have been cases of acute generalized exanterriatic pustulosis in patients treated with preparations of piperacicline and hydrated piperacicline / tazobactam (none in the last three years). acute generalized exanthematous pustulosis: cases of acute generalized pustular psoriasis exantematicase have been reported in patients treated with tazobactam / piperacillin hydrate in both japanese coma abroad. on the other hand, cases of acute generalized exanthematous pustulosis have been reported in patients treated with sodium piperacillin in japan.

Device

Piperacilin - Tazobactam
  • Model / Serial
  • Product Description
    Piperacillin is an extended spectrum beta-lactam antibiotic that belongs to the ureidopenicillin class. The pair is usually co-administered with the beta-lactamase tazobactam inhibitor, leading to increased activity including Gram positive and Gram negative pathogens, and aerobic organisms such as Pseudomonas aeruginosa. Piperacillin is used for the treatment of infections susceptible to strains of microorganisms such as staphylococcus, streptococcus and klebsiella genus. It is indicated for pulmonary, intra-abdominal infections, complicated urinary tract infections and others.
  • Manufacturer
    Pharmayect SA, Laboratorio Libra SA, Laboratorio Richet SA, Aurobindo Pharma Ltd

Manufacturer

Pharmayect SA, Laboratorio Libra SA, Laboratorio Richet SA, Aurobindo Pharma Ltd
  • Source
    HMP